Nn9535-4416
Research payments
$2,718,465
Through program year 2024, $2,718,465 in research payments was reported against Nn9535-4416, across 1,669 payments, paid by Novo Nordisk AS.
- Paid by
- Novo Nordisk AS
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $1,695 | 2 |
| 2023 | Research | $159,216 | 115 |
| 2022 | Research | $530,960 | 354 |
| 2021 | Research | $736,649 | 449 |
| 2020 | Research | $624,726 | 466 |
| 2019 | Research | $665,219 | 283 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Cedrice Davis Marietta, GA Named on 29 payments
- Aliaksandr Trusau Oconto, WI Named on 25 payments
- Arvind Krishna Canton, OH Named on 22 payments
- Richard Murphy Humboldt, TN Named on 22 payments
- Daniel Horton Lynchburg, VA Named on 21 payments
- Kent Lehman Berne, IN Named on 21 payments
- Angela Davis Statesboro, GA Named on 20 payments
- Sean Lynch Augusta, GA Named on 17 payments
- Bryce Palchick Pittsburgh, PA Named on 17 payments
- Bryan Feldman Columbus, OH Named on 17 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.